3H-TVX Q 7821: Identification of 5-HT1 Binding Sites As Target for a Novel Putative Anxiolytic

Overview

Journal Naunyn Schmiedebergs Arch Pharmacol

Specialty Pharmacology

Date 1985 Feb 1

PMID 2859533

Citations 37

Authors

W U Dompert

T Glaser

J Traber

Affiliations

Soon will be listed here.

Abstract

In order to clarify the mechanism of action of the putative nonbenzodiazepine anxiolytic TVX Q 7821 [2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1, 2-benzisothiazol-3-(2H)one-1,1-dioxidehydrochloride], binding studies with the radio labelled compound were performed. 3H-TVX Q 7821 bound rapidly, reversibly and in a saturable manner with high affinity to calf brain structures with preference for the hippocampus (KD 1.62 nmol/l; Bmax 320 fmol/ mg protein). 3H-TVX Q 7821 binding was displaced only by 5-hydroxytryptamine and its agonists and antagonists including spiperone, but was not displaced by a variety of other neurotransmitters and drugs. The 5-HT2 receptor antagonist ketanserin was a weak displacer. The hippocampal binding sites for 3H-TVX Q 7821 were pharmacologically very similar to the 5-HT1-binding sites in this region. TVX Q 7821 is likely to be an important tool in research on functional aspects of 5-HT1 binding sites.

Citing Articles

In vivo relationship between serotonin 1A receptor binding and gray matter volume in the healthy brain and in major depressive disorder.

Zanderigo F, Pantazatos S, Rubin-Falcone H, Ogden R, Chhetry B, Sullivan G Brain Struct Funct. 2018; 223(6):2609-2625.

PMID: 29550938 PMC: 6450806. DOI: 10.1007/s00429-018-1649-6.

The 5-HT7 receptor as a potential target for treating drug and alcohol abuse.

Hauser S, Hedlund P, Roberts A, Sari Y, Bell R, Engleman E Front Neurosci. 2015; 8:448.

PMID: 25628528 PMC: 4292232. DOI: 10.3389/fnins.2014.00448.

Behavioral and pharmacogenetics of aggressive behavior.

Takahashi A, Quadros I, de Almeida R, Miczek K Curr Top Behav Neurosci. 2012; 12:73-138.

PMID: 22297576 PMC: 3864145. DOI: 10.1007/7854_2011_191.

Brain serotonin receptors and transporters: initiation vs. termination of escalated aggression.

Takahashi A, Quadros I, de Almeida R, Miczek K Psychopharmacology (Berl). 2010; 213(2-3):183-212.

PMID: 20938650 PMC: 3684010. DOI: 10.1007/s00213-010-2000-y.

The 5-HT1A receptor and the stimulus effects of LSD in the rat.

Reissig C, Eckler J, Rabin R, Winter J Psychopharmacology (Berl). 2005; 182(2):197-204.

PMID: 16025319 PMC: 1266303. DOI: 10.1007/s00213-005-0068-6.

References

Biegon A, Rainbow T, McEwen B . Quantitative autoradiography of serotonin receptors in the rat brain. Brain Res. 1982; 242(2):197-204. DOI: 10.1016/0006-8993(82)90301-8. View

Glaser T, Traber J . Buspirone: action on serotonin receptors in calf hippocampus. Eur J Pharmacol. 1983; 88(1):137-8. DOI: 10.1016/0014-2999(83)90404-1. View

Gozlan H, El Mestikawy S, PICHAT L, Glowinski J, Hamon M . Identification of presynaptic serotonin autoreceptors using a new ligand: 3H-PAT. Nature. 1983; 305(5930):140-2. DOI: 10.1038/305140a0. View

Samanin R, Mennini T, Ferraris A, Bendotti C, Borsini F, Garattini S . Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn Schmiedebergs Arch Pharmacol. 1979; 308(2):159-63. DOI: 10.1007/BF00499059. View

Leysen J, Awouters F, Kennis L, Laduron P, Vandenberk J, Janssen P . Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci. 1981; 28(9):1015-22. DOI: 10.1016/0024-3205(81)90747-5. View

Tobler H, Engel G . Affinity spectra: a novel way for the evaluation of equilibrium binding experiments. Naunyn Schmiedebergs Arch Pharmacol. 1983; 322(3):183-92. DOI: 10.1007/BF00500763. View

Traber J, Davies M, Dompert W, Glaser T, Schuurman T, Seidel P . Brain serotonin receptors as a target for the putative anxiolytic TVX Q 7821. Brain Res Bull. 1984; 12(6):741-4. DOI: 10.1016/0361-9230(84)90155-2. View

Arvidsson L, Hacksell U, Nilsson J, Hjorth S, Carlsson A, Lindberg P . 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist. J Med Chem. 1981; 24(8):921-3. DOI: 10.1021/jm00140a002. View

Pedigo N, Yamamura H, Nelson D . Discrimination of multiple [3H]5-hydroxytryptamine binding sites by the neuroleptic spiperone in rat brain. J Neurochem. 1981; 36(1):220-6. DOI: 10.1111/j.1471-4159.1981.tb02397.x. View

10.

Leysen J . Problems in in vitro receptor binding studies and identification and role of serotonin receptor sites. Neuropharmacology. 1984; 23(2B):247-54. DOI: 10.1016/0028-3908(84)90066-2. View

11.

Goldberg H, Finnerty R . The comparative efficacy of buspirone and diazepam in the treatment of anxiety. Am J Psychiatry. 1979; 136(9):1184-7. DOI: 10.1176/ajp.136.9.1184. View

12.

Safdy M, Kurchacova E, SCHUT R, Vidrio H, Hong E . Tryptophan analogues. 1. Synthesis and antihypertensive activity of positional isomers. J Med Chem. 1982; 25(6):723-30. DOI: 10.1021/jm00348a022. View

13.

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

14.

Middlemiss D, Fozard J . 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site. Eur J Pharmacol. 1983; 90(1):151-3. DOI: 10.1016/0014-2999(83)90230-3. View

15.

Marcinkiewicz M, Verge D, Gozlan H, PICHAT L, Hamon M . Autoradiographic evidence for the heterogeneity of 5-HT1 sites in the rat brain. Brain Res. 1984; 291(1):159-63. DOI: 10.1016/0006-8993(84)90664-4. View

16.

Peroutka S, Snyder S . Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. Mol Pharmacol. 1979; 16(3):687-99. View